The complaint at ER triage: Weakness, fatigue, near syncope of several days' duration, vomiting, and decreased sensorium. The findings: O 2sat: 88% on room air. BP: 88 systolic. Telemetry: Sinus ...

The direct thrombin inhibitor bivalirudin is superior to heparin plus a glycoprotein IIb/IIIa inhibitor (GPI) at reducing bleeding in patients with non-ST-segment elevation myocardial infarction ...

NEW ORLEANS, LA — In a study of more than 9000 patients who were hospitalized for non-ST-segment-elevation MI (NSTEMI), those who received early revascularization (within 24 hours) were more likely to ...

An analysis of NSTEMI patients who undergo coronary revascularization within 24 hours of hospitalization showed an increased reduction in mortality, marking the first time this difference has been ...

In patients with non-ST-segment elevation myocardial infarction (NSTEMI), routine use of a strategy involving angiography and, when necessary, revascularization can reduce both short- and long-term ...

An analysis of NSTEMI patients who undergo coronary revascularization within 24 hours of hospitalization showed an increased reduction in mortality, marking the first time this difference has been ...

Results of the ISAR-REACT 4 study have shown that combined therapy of abciximab and unfractionated heparin is not associated with a lower 30-day rate of death, large recurrent myocardial infarction, ...

Following cardiac catheterization, patients with ST-segment elevation myocardial infarction (STEMI) have a higher risk of short-term mortality than patients with non-STEMI (NSTEMI), who have a higher ...

Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

BARCELONA, Spain – Monday 1 September: A method for measuring coronary artery blockage in heart attack patients can help more than one fifth of them avoid stents or surgery, according to a British ...